Patent Number: 8,871,250

Title: Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine

Abstract: The present invention provides a method for treating an individual who is afflicted with a cancer, such as non-small cell lung cancer or prostate cancer, by administering to that individual a MUC-1-based formulation. The formulation may be a MUC-1 based liposomal vaccine formulation.

Inventors: Longenecker; B. Michael (Alberta, CA)

Assignee: Oncothyreon Inc.

International Classification: A61K 9/127 (20060101)

Expiration Date: 2018-10-28 0:00:00